期刊
CLINICAL KIDNEY JOURNAL
卷 15, 期 2, 页码 357-359出版社
OXFORD UNIV PRESS
DOI: 10.1093/ckj/sfab181
关键词
ANCA-associated vasculitis; focal necrotizing glomerulonephritis; MPO-ANCA; mRNA vaccine; SARS-CoV-2
COVID-19 vaccines may increase the risk of immune-mediated diseases, as shown in a case of ANCA-associated vasculitis following vaccination with the BNT162b2 vaccine. The causal relationship between the vaccine and vasculitis is uncertain, but environmental and genetic factors may have played a role in the development of the disease, with the vaccine potentially triggering a chain reaction.
Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has demonstrated high efficacy at preventing coronavirus disease 2019 (COVID-19) and a favorable safety profile, however it has also been reported that COVID-19 vaccines may put increase of immune-mediated disease. We herein report a case of MPO-anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis following the mRNA vaccine BNT162b2 (Pfizer/BioNTech) for COVID-19. Although the causal relationship between vaccine and ANCA-associated vasculitis is uncertain, environmental and genetic factors may have set the stage for the development of vasculitis, and the vaccine may have triggered a domino effect.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据